Objectives: We determined the complete nucleotide sequence of pKOX105, a 54 641 bp plasmid from a Klebsiella oxytoca strain that was isolated from a resident of a long-term-care facility in Bolzano, Italy.
Introduction
Although Enterobacteriaceae with carbapenemases remain rare in Italy, isolates with metallo-b-lactamases (MBLs) have been isolated from acute-care hospital patients and longterm-care-facility (LTCF) residents in Bolzano since 2005. 1 -5 All the MBLs so far characterized from these isolates have proved to be VIM type. Producers included 24 clinical isolates of four species in 2005 -7, and 0.6% -0.7% of all routine clinical isolates of 10 species in 2008 -09. 3, 5 Moreover, 6.3% of LTCF residents and 1.5% of LTCF staff members carried Enterobacteriaceae with VIM carbapenemases in their gut flora in 2008. 4 In the isolates studied we found that bla VIM-1 was linked with the fluoroquinolone resistance gene qnrS1 and the extendedspectrum b-lactamase (ESBL) gene bla SHV-12 with these genes carried on related IncN plasmids. 2 -4 Here we have determined the complete DNA sequence of a representative host plasmid, pKOX105, bearing these three resistance genes and have compared it with other fully sequenced IncN plasmids, specifically those encoding KPC-2 and KPC-3 carbapenemases in the USA.
Materials and methods

Source of pKOX105
The 55 kb plasmid pKOX105 selected for sequencing was transformed from a Klebsiella oxytoca isolate recovered from the gut flora of an LTCF resident into Escherichia coli DH10B. The isolate and transformant were both PCR positive for bla VIM-1 , qnrS1 and bla SHV-12 . pKOX105 was identical by restriction fragment length polymorphism (RFLP) analysis to an E. coli plasmid obtained from a different patient in the same LTCF and was similar to plasmids from other LTCF screening and hospital isolates. 4 
Plasmid sequencing
The plasmid was sequenced by Eurofins Genetic Services Ltd (Germany) using a shotgun approach. Briefly, randomly sheared plasmid fragments of 2-3 kb were cloned into the pGEM-Teasy vector and then transformed into E. coli DH10B. Inserts were sequenced by dye terminator chemistry. Sequences were assembled using the Staden Package. Combinatorial PCRs, directed PCRs and walking reads were used to assemble the contigs and to fill in gaps.
Bioinformatics
Open reading frames (ORFs) were predicted and annotated using the DNAMAN 5.2.10 software (Lynnon BioSoft; Lynnon Corporation, http:// www.lynnon.com). Each predicted protein was compared against an all-protein database using BlastP (http://blast.ncbi.nlm.nih.gov/Blast.cgi) with a minimum cut-off of 30% identity over 80% length coverage. Gene sequences were further compared and aligned with GenBank data using BLAST (http://blast.ncbi.nlm.nih.gov/Blast.cgi) and CLUSTAL W (http://www.ebi.ac.uk/clustalw). The IncN plasmid R46 (GenBank AY046276) was used as a reference for annotating pKOX105, with IncN plasmids p9 (FJ223607) and p12 (NC_011385.1) used for additional comparison. Data files were compiled using Sequin (http://www.ncbi.nlm.nih. gov/Sequin/).
Nucleotide sequence
The GenBank accession number for the pKOX105 plasmid is HM126016.
Results and discussion
Analysis of pKOX105 DNA sequence
Plasmid pKOX105 is a circular molecule of 54641 bp, belonging to incompatibility group N and harbouring 69 predicted genes (Table 1) , including bla VIM-1 , bla SHV-12 , qnrS1, aacA4 and dfrA14, which variously confer resistance to carbapenems, oxyiminocephalosporins, quinolones, aminoglycosides and trimethoprim. The plasmid comprised a 35180 bp 'core genome' region encoding characteristic IncN plasmid replication, horizontal transfer, maintenance and stability functions, and a discontinuous 19 461 bp variable region, which included the resistance genes and modules composed of insertion sequences or transposons ( Figure 1) .
The conserved region encoded the IncN replicon, including the repA replicase gene and the iterons (AY046276). pKOX105, as previously described for all the IncN plasmids, also encoded the MucA-MucB DNA polymerase Y-family system, involved in mutagenesis enhancement, the ArdA-ArdB antirestriction system and the StbA-StbB -StbC system, guaranteeing stable plasmid inheritance during bacterial cell division. Unlike other IncN plasmids, pKOX105 lacked the ccgC and ccgD genes, encoding products that protect plasmid DNA from type I restriction enzymes. 6 The antibiotic resistance region(s) of pKOX105 was split into two parts of 14806 and 4655 bp, separated by a 17158 bp region encoding the EcoRII restriction enzyme, the EcoRII restriction/antirestriction cytosine methyltransferase, the killer protein KikA for plasmid maintenance and an incomplete transfer region composed of the genes traG to traL. The 14806 bp resistance region had an IS26 module carrying the bla SHV-12 and qnrS1 genes, and a class 1 integron, with its 3 ′ -conserved sequence (3 ′ -CS) truncated by the insertion of an IS6100 element. This integron carried the dfrA14 gene cassette, conferring trimethoprim resistance. The 4655 bp resistance region contained a class 1 integron lying between an IS26 element and the uvp1 gene; this integron carried the bla VIM-1 and aacA4 resistance gene cassettes and its 3 ′ -CS was truncated by an IS26 element. Uvp1 is an integron-associated resolvase previously identified on R46, the IncN reference plasmid. 7 Its presence here possibly suggests that the bla VIM-1 -carrying integron of pKOX105 is derived from the integron of R46 by gene cassette replacement.
The integration sites of the 14 806 and 4655 bp antibiotic resistance regions were downstream of the fipA and nuc genes, respectively, and the insertion of a putative transposase gene of the Tn1525 transposon, flanking the IS26 module carrying the bla SHV-12 and qnrS1 genes, had caused the deletion at the 3 ′ -end of the fipA gene. Another transposase gene of the Tn1525 transposon flanking the bla VIM-1 -carrying integron was identified at the 3 ′ -end of the nuc gene. This configuration may have been generated by insertion of an entire resistance region between the fipA and nuc genes, with a subsequent inversion event, probably mediated by the IS26 and IS6100 elements, involving the plasmid region lying between the nuc gene and the EcoRII restriction/antirestriction system ( Figure 1 ).
Comparison of pKOX105 with IncN plasmids encoding KPC carbapenemase
The pKOX105 structure was compared with two fully sequenced IncN plasmids, p9 and p12, that carried bla KPC carbapenem resistance genes identified in Klebsiella pneumoniae and K. oxytoca strains isolated at a New York City hospital in 2005. 8 Plasmids pKOX105 and p9 shared similar IncN scaffolds but in contrast to pKOX105, p9 (70.6 kb) had the type I antirestriction ccgC and ccgD genes and a functional conjugative apparatus, and carried two copies of bla KPC-2 associated with Tn4401b elements inserted in an inverted orientation (FJ223607). The integration site for the antibiotic resistance region of p9 lies downstream of the EcoRII restriction/antirestriction system and the uvp1 gene (Figure 1 ). Plasmid p12 (75.6 kb) lacked the antirestriction ccgC, ccgD and ardA genes and had an 10 kb resistance region carrying the Tn4401b element harbouring bla KPC-3 along with sul1, aph, aadA, aacA4, bla TEM-1 and bla OXA-9 , conferring resistance to sulphonamides, aminoglycosides and b-lactams. This resistance region had integrated into the p12 scaffold between the fipA and nuc genes, and identical transposase genes to those observed in pKOX105 were identified at these sites, causing the same 3 ′ deletion of fipA. p12 had a nonfunctional transfer region due to insertion of the ars operon, encoding resistance to arsenic, between traB and traA; it also carried a class 1 integron with the dfrA14 gene cassette, located downstream of the EcoRII restriction/antirestriction system and flanked by the tnpM gene of the Tn21 transposon and an IS6100 element. pKOX105 had a tnpM-IS6100-associated integron carrying the dfrA14 gene cassette at the same site (Figure 1) . Thus, although pKOX105 and p12 carry different antibiotic resistance genes, they share the same integration sites for the acquisition of IS26-mediated resistance determinants and carried similar integrons in the same position. These plasmids that show very well-conserved IncN scaffolds (100% amino acid identity among the proteins composing their core genome, Table 1 ) may therefore originate from a common ancestor that has evolved by acquisition, deletion and inversion events generating the pKOX105 and p12 IncN variants. It is impressive and worrying that pKOX105, p9 and p12 seem independently to have acquired distinct carbapenem resistance genes, each of which is associated with a different mobile genetic element (the integron-borne bla VIM-1 cassette in pKOX105 and the Tn4401::bla KPC in p9 and p12). Our comparative analyses clearly show that p9 and p12 acquired their KPC determinants by independent acquisition events involving different integration sites, whereas pKOX105 and p12 have different resistance determinants integrated into the same site within fipA. This could represent a 'hot spot' for integration of transposable elements in the IncN plasmid scaffold.
Conclusions
This analysis provides insights into the mechanisms determining the successful spread of plasmids belonging to the IncN family, and their role as vehicles for the spread of carbapenem resistance genes. IncN plasmids have been reported in association with the most prevalent ESBL, metallo-and non-metallo-carbapenemase and plasmid-mediated quinolone resistance genes, including the emerging KPC-2 and KPC-3 carbapenem resistance genes. 9 IncN plasmids bearing bla VIM-1 , bla SHV-12 and qnrS1 were identified in 2007 in two K. pneumoniae isolates from Norway, suggesting a wider diffusion of pKOX105-related plasmids in Europe. 10 Those carrying different bla VIM-1 integrons were identified in K. pneumoniae and E. coli isolates from Greece, suggesting repeated independent acquisition of bla VIM-1 integrons by this plasmid type.
11
IncN plasmids carrying qnrS1 but not bla VIM-1 were previously described in multiple Salmonella enterica serovars from the Netherlands and the UK. 12, 13 Interestingly, an American study not predicated on antibiotic resistance found that IncN plasmids were highly prevalent in poultry faecal flora, but absent among E. coli isolates from human urinary tract infections and from the gut flora of healthy human subjects suggesting that these plasmids may have a reservoir in animal commensal flora.
14 Nevertheless, Moodley and Guardabassi 15 demonstrated that IncN plasmids carrying bla CTX-M-1 were quickly transmitted within a farm among pigs and the farm workers, across multiple E. coli lineages, demonstrating their capacity to spread in the commensal flora of both animals and humans.
Differences exist in the variable regions of IncN plasmids, but their backbones are generally well conserved and probably encode factors that promote their success. These include multiple systems to protect the plasmid from restriction, to ensure stable plasmid inheritance along with other features yet to be defined. It is clear, however, that these multidrug resistance IncN plasmids have been moving beyond the hospital environment for some years among colonizers and pathogenic bacteria from residents of LTCFs and even staff members in Bolzano, promoting the successful dissemination of carbapenem resistance in the hospital setting. 
